 | • レポートコード：GIR-2104Z00858 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、肛門がんのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。肛門がんの種類別市場規模（フルオロウラシル、シスプラチン、カルボプラチン、その他）、用途別市場規模（病院、介護センター、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・肛門がんの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline、Spectrum Pharmaceuticals、Hospira、Global BioPharma、Advaxis、Amgen Inc、Atara Biotherapeutics、Bayer、Cell Medica、Eli Lilly、Genticel、ISA Pharmaceuticals、Merck＆Co、Millennium Pharmaceuticals、Novartis、Ono Pharmaceutical、Oryx、PDS Biotechnology、Sun Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：フルオロウラシル、シスプラチン、カルボプラチン、その他 ・用途別分析2016年-2026年：病院、介護センター、薬局、その他 ・肛門がんの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・肛門がんのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・肛門がんのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・肛門がんの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・肛門がんの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anal Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anal Cancer size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Anal Cancer market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Anal Cancer market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fluorouracil
Cisplatin
Carboplatin
Other
Market segment by Application, can be divided into
Hospitals
Long-term care centers
Pharmacies
Other
Market segment by players, this report covers
GlaxoSmithKline
Spectrum Pharmaceuticals
Hospira
Global BioPharma
Advaxis
Amgen Inc
Atara Biotherapeutics
Bayer
Cell Medica
Eli Lilly
Genticel
ISA Pharmaceuticals
Merck＆Co
Millennium Pharmaceuticals
Novartis
Ono Pharmaceutical
Oryx
PDS Biotechnology
Sun Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Anal Cancer
1.2 Classification of Anal Cancer by Type
1.2.1 Overview: Global Anal Cancer Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Anal Cancer Revenue Market Share by Type in 2020
1.2.3 Fluorouracil
1.2.4 Cisplatin
1.2.5 Carboplatin
1.2.6 Other
1.3 Global Anal Cancer Market by Application
1.3.1 Overview: Global Anal Cancer Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Long-term care centers
1.3.4 Pharmacies
1.3.5 Other
1.4 Global Anal Cancer Market Size & Forecast
1.5 Global Anal Cancer Market Size and Forecast by Region
1.5.1 Global Anal Cancer Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Anal Cancer Market Size by Region, (2016-2021)
1.5.3 North America Anal Cancer Market Size and Prospect (2016-2026)
1.5.4 Europe Anal Cancer Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Anal Cancer Market Size and Prospect (2016-2026)
1.5.6 South America Anal Cancer Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Anal Cancer Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Anal Cancer Market Drivers
1.6.2 Anal Cancer Market Restraints
1.6.3 Anal Cancer Trends Analysis
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Anal Cancer Product and Solutions
2.1.4 GlaxoSmithKline Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GlaxoSmithKline Recent Developments and Future Plans
2.2 Spectrum Pharmaceuticals
2.2.1 Spectrum Pharmaceuticals Details
2.2.2 Spectrum Pharmaceuticals Major Business
2.2.3 Spectrum Pharmaceuticals Anal Cancer Product and Solutions
2.2.4 Spectrum Pharmaceuticals Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
2.3 Hospira
2.3.1 Hospira Details
2.3.2 Hospira Major Business
2.3.3 Hospira Anal Cancer Product and Solutions
2.3.4 Hospira Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Hospira Recent Developments and Future Plans
2.4 Global BioPharma
2.4.1 Global BioPharma Details
2.4.2 Global BioPharma Major Business
2.4.3 Global BioPharma Anal Cancer Product and Solutions
2.4.4 Global BioPharma Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Global BioPharma Recent Developments and Future Plans
2.5 Advaxis
2.5.1 Advaxis Details
2.5.2 Advaxis Major Business
2.5.3 Advaxis Anal Cancer Product and Solutions
2.5.4 Advaxis Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Advaxis Recent Developments and Future Plans
2.6 Amgen Inc
2.6.1 Amgen Inc Details
2.6.2 Amgen Inc Major Business
2.6.3 Amgen Inc Anal Cancer Product and Solutions
2.6.4 Amgen Inc Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Amgen Inc Recent Developments and Future Plans
2.7 Atara Biotherapeutics
2.7.1 Atara Biotherapeutics Details
2.7.2 Atara Biotherapeutics Major Business
2.7.3 Atara Biotherapeutics Anal Cancer Product and Solutions
2.7.4 Atara Biotherapeutics Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Atara Biotherapeutics Recent Developments and Future Plans
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Anal Cancer Product and Solutions
2.8.4 Bayer Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Bayer Recent Developments and Future Plans
2.9 Cell Medica
2.9.1 Cell Medica Details
2.9.2 Cell Medica Major Business
2.9.3 Cell Medica Anal Cancer Product and Solutions
2.9.4 Cell Medica Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Cell Medica Recent Developments and Future Plans
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Anal Cancer Product and Solutions
2.10.4 Eli Lilly Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Eli Lilly Recent Developments and Future Plans
2.11 Genticel
2.11.1 Genticel Details
2.11.2 Genticel Major Business
2.11.3 Genticel Anal Cancer Product and Solutions
2.11.4 Genticel Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Genticel Recent Developments and Future Plans
2.12 ISA Pharmaceuticals
2.12.1 ISA Pharmaceuticals Details
2.12.2 ISA Pharmaceuticals Major Business
2.12.3 ISA Pharmaceuticals Anal Cancer Product and Solutions
2.12.4 ISA Pharmaceuticals Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 ISA Pharmaceuticals Recent Developments and Future Plans
2.13 Merck＆Co
2.13.1 Merck＆Co Details
2.13.2 Merck＆Co Major Business
2.13.3 Merck＆Co Anal Cancer Product and Solutions
2.13.4 Merck＆Co Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Merck＆Co Recent Developments and Future Plans
2.14 Millennium Pharmaceuticals
2.14.1 Millennium Pharmaceuticals Details
2.14.2 Millennium Pharmaceuticals Major Business
2.14.3 Millennium Pharmaceuticals Anal Cancer Product and Solutions
2.14.4 Millennium Pharmaceuticals Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Millennium Pharmaceuticals Recent Developments and Future Plans
2.15 Novartis
2.15.1 Novartis Details
2.15.2 Novartis Major Business
2.15.3 Novartis Anal Cancer Product and Solutions
2.15.4 Novartis Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Novartis Recent Developments and Future Plans
2.16 Ono Pharmaceutical
2.16.1 Ono Pharmaceutical Details
2.16.2 Ono Pharmaceutical Major Business
2.16.3 Ono Pharmaceutical Anal Cancer Product and Solutions
2.16.4 Ono Pharmaceutical Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Ono Pharmaceutical Recent Developments and Future Plans
2.17 Oryx
2.17.1 Oryx Details
2.17.2 Oryx Major Business
2.17.3 Oryx Anal Cancer Product and Solutions
2.17.4 Oryx Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Oryx Recent Developments and Future Plans
2.18 PDS Biotechnology
2.18.1 PDS Biotechnology Details
2.18.2 PDS Biotechnology Major Business
2.18.3 PDS Biotechnology Anal Cancer Product and Solutions
2.18.4 PDS Biotechnology Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 PDS Biotechnology Recent Developments and Future Plans
2.19 Sun Pharma
2.19.1 Sun Pharma Details
2.19.2 Sun Pharma Major Business
2.19.3 Sun Pharma Anal Cancer Product and Solutions
2.19.4 Sun Pharma Anal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Sun Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Anal Cancer Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Anal Cancer Players Market Share
3.2.2 Top 10 Anal Cancer Players Market Share
3.2.3 Market Competition Trend
3.3 Anal Cancer Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Anal Cancer Revenue and Market Share by Type (2016-2021)
4.2 Global Anal Cancer Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Anal Cancer Revenue Market Share by Application (2016-2021)
5.2 Anal Cancer Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Anal Cancer Revenue by Type (2016-2026)
6.2 North America Anal Cancer Revenue by Application (2016-2026)
6.3 North America Anal Cancer Market Size by Country
6.3.1 North America Anal Cancer Revenue by Country (2016-2026)
6.3.2 United States Anal Cancer Market Size and Forecast (2016-2026)
6.3.3 Canada Anal Cancer Market Size and Forecast (2016-2026)
6.3.4 Mexico Anal Cancer Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Anal Cancer Revenue by Type (2016-2026)
7.2 Europe Anal Cancer Revenue by Application (2016-2026)
7.3 Europe Anal Cancer Market Size by Country
7.3.1 Europe Anal Cancer Revenue by Country (2016-2026)
7.3.2 Germany Anal Cancer Market Size and Forecast (2016-2026)
7.3.3 France Anal Cancer Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Anal Cancer Market Size and Forecast (2016-2026)
7.3.5 Russia Anal Cancer Market Size and Forecast (2016-2026)
7.3.6 Italy Anal Cancer Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Anal Cancer Revenue by Type (2016-2026)
8.2 Asia-Pacific Anal Cancer Revenue by Application (2016-2026)
8.3 Asia-Pacific Anal Cancer Market Size by Region
8.3.1 Asia-Pacific Anal Cancer Revenue by Region (2016-2026)
8.3.2 China Anal Cancer Market Size and Forecast (2016-2026)
8.3.3 Japan Anal Cancer Market Size and Forecast (2016-2026)
8.3.4 South Korea Anal Cancer Market Size and Forecast (2016-2026)
8.3.5 India Anal Cancer Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Anal Cancer Market Size and Forecast (2016-2026)
8.3.7 Australia Anal Cancer Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Anal Cancer Revenue by Type (2016-2026)
9.2 South America Anal Cancer Revenue by Application (2016-2026)
9.3 South America Anal Cancer Market Size by Country
9.3.1 South America Anal Cancer Revenue by Country (2016-2026)
9.3.2 Brazil Anal Cancer Market Size and Forecast (2016-2026)
9.3.3 Argentina Anal Cancer Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Anal Cancer Revenue by Type (2016-2026)
10.2 Middle East & Africa Anal Cancer Revenue by Application (2016-2026)
10.3 Middle East & Africa Anal Cancer Market Size by Country
10.3.1 Middle East & Africa Anal Cancer Revenue by Country (2016-2026)
10.3.2 Turkey Anal Cancer Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Anal Cancer Market Size and Forecast (2016-2026)
10.3.4 UAE Anal Cancer Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Anal Cancer Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Anal Cancer Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Anal Cancer Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Anal Cancer Revenue (USD Million) by Region (2016-2021)
Table 5. Global Anal Cancer Revenue Market Share by Region (2021-2026)
Table 6. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 7. GlaxoSmithKline Major Business
Table 8. GlaxoSmithKline Anal Cancer Product and Solutions
Table 9. GlaxoSmithKline Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Spectrum Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 11. Spectrum Pharmaceuticals Major Business
Table 12. Spectrum Pharmaceuticals Anal Cancer Product and Solutions
Table 13. Spectrum Pharmaceuticals Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Hospira Corporate Information, Head Office, and Major Competitors
Table 15. Hospira Major Business
Table 16. Hospira Anal Cancer Product and Solutions
Table 17. Hospira Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Global BioPharma Corporate Information, Head Office, and Major Competitors
Table 19. Global BioPharma Major Business
Table 20. Global BioPharma Anal Cancer Product and Solutions
Table 21. Global BioPharma Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Advaxis Corporate Information, Head Office, and Major Competitors
Table 23. Advaxis Major Business
Table 24. Advaxis Anal Cancer Product and Solutions
Table 25. Advaxis Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Amgen Inc Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Inc Major Business
Table 28. Amgen Inc Anal Cancer Product and Solutions
Table 29. Amgen Inc Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Atara Biotherapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Atara Biotherapeutics Major Business
Table 32. Atara Biotherapeutics Anal Cancer Product and Solutions
Table 33. Atara Biotherapeutics Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Bayer Corporate Information, Head Office, and Major Competitors
Table 35. Bayer Major Business
Table 36. Bayer Anal Cancer Product and Solutions
Table 37. Bayer Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Cell Medica Corporate Information, Head Office, and Major Competitors
Table 39. Cell Medica Major Business
Table 40. Cell Medica Anal Cancer Product and Solutions
Table 41. Cell Medica Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 43. Eli Lilly Major Business
Table 44. Eli Lilly Anal Cancer Product and Solutions
Table 45. Eli Lilly Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Genticel Corporate Information, Head Office, and Major Competitors
Table 47. Genticel Major Business
Table 48. Genticel Anal Cancer Product and Solutions
Table 49. Genticel Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. ISA Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 51. ISA Pharmaceuticals Major Business
Table 52. ISA Pharmaceuticals Anal Cancer Product and Solutions
Table 53. ISA Pharmaceuticals Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Merck＆Co Corporate Information, Head Office, and Major Competitors
Table 55. Merck＆Co Major Business
Table 56. Merck＆Co Anal Cancer Product and Solutions
Table 57. Merck＆Co Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Millennium Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. Millennium Pharmaceuticals Major Business
Table 60. Millennium Pharmaceuticals Anal Cancer Product and Solutions
Table 61. Millennium Pharmaceuticals Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Novartis Corporate Information, Head Office, and Major Competitors
Table 63. Novartis Major Business
Table 64. Novartis Anal Cancer Product and Solutions
Table 65. Novartis Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Ono Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 67. Ono Pharmaceutical Major Business
Table 68. Ono Pharmaceutical Anal Cancer Product and Solutions
Table 69. Ono Pharmaceutical Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Oryx Corporate Information, Head Office, and Major Competitors
Table 71. Oryx Major Business
Table 72. Oryx Anal Cancer Product and Solutions
Table 73. Oryx Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. PDS Biotechnology Corporate Information, Head Office, and Major Competitors
Table 75. PDS Biotechnology Major Business
Table 76. PDS Biotechnology Anal Cancer Product and Solutions
Table 77. PDS Biotechnology Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Sun Pharma Corporate Information, Head Office, and Major Competitors
Table 79. Sun Pharma Major Business
Table 80. Sun Pharma Anal Cancer Product and Solutions
Table 81. Sun Pharma Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Global Anal Cancer Revenue (USD Million) by Players (2019-2021)
Table 83. Global Anal Cancer Revenue Share by Players (2019-2021)
Table 84. Breakdown of Anal Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Anal Cancer Players Head Office, Products and Services Provided
Table 86. Anal Cancer Mergers & Acquisitions in the Past Five Years
Table 87. Anal Cancer New Entrants and Expansion Plans
Table 88. Global Anal Cancer Revenue (USD Million) by Type (2016-2021)
Table 89. Global Anal Cancer Revenue Share by Type (2016-2021)
Table 90. Global Anal Cancer Revenue Forecast by Type (2021-2026)
Table 91. Global Anal Cancer Revenue by Application (2016-2021)
Table 92. Global Anal Cancer Revenue Forecast by Application (2021-2026)
Table 93. North America Anal Cancer Revenue by Type (2016-2021) & (USD Million)
Table 94. North America Anal Cancer Revenue by Type (2021-2026) & (USD Million)
Table 95. North America Anal Cancer Revenue by Application (2016-2021) & (USD Million)
Table 96. North America Anal Cancer Revenue by Application (2021-2026) & (USD Million)
Table 97. North America Anal Cancer Revenue by Country (2016-2021) & (USD Million)
Table 98. North America Anal Cancer Revenue by Country (2021-2026) & (USD Million)
Table 99. Europe Anal Cancer Revenue by Type (2016-2021) & (USD Million)
Table 100. Europe Anal Cancer Revenue by Type (2021-2026) & (USD Million)
Table 101. Europe Anal Cancer Revenue by Application (2016-2021) & (USD Million)
Table 102. Europe Anal Cancer Revenue by Application (2021-2026) & (USD Million)
Table 103. Europe Anal Cancer Revenue by Country (2016-2021) & (USD Million)
Table 104. Europe Anal Cancer Revenue by Country (2021-2026) & (USD Million)
Table 105. Asia-Pacific Anal Cancer Revenue by Type (2016-2021) & (USD Million)
Table 106. Asia-Pacific Anal Cancer Revenue by Type (2021-2026) & (USD Million)
Table 107. Asia-Pacific Anal Cancer Revenue by Application (2016-2021) & (USD Million)
Table 108. Asia-Pacific Anal Cancer Revenue by Application (2021-2026) & (USD Million)
Table 109. Asia-Pacific Anal Cancer Revenue by Region (2016-2021) & (USD Million)
Table 110. Asia-Pacific Anal Cancer Revenue by Region (2021-2026) & (USD Million)
Table 111. South America Anal Cancer Revenue by Type (2016-2021) & (USD Million)
Table 112. South America Anal Cancer Revenue by Type (2021-2026) & (USD Million)
Table 113. South America Anal Cancer Revenue by Application (2016-2021) & (USD Million)
Table 114. South America Anal Cancer Revenue by Application (2021-2026) & (USD Million)
Table 115. South America Anal Cancer Revenue by Country (2016-2021) & (USD Million)
Table 116. South America Anal Cancer Revenue by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Anal Cancer Revenue by Type (2016-2021) & (USD Million)
Table 118. Middle East & Africa Anal Cancer Revenue by Type (2021-2026) & (USD Million)
Table 119. Middle East & Africa Anal Cancer Revenue by Application (2016-2021) & (USD Million)
Table 120. Middle East & Africa Anal Cancer Revenue by Application (2021-2026) & (USD Million)
Table 121. Middle East & Africa Anal Cancer Revenue by Country (2016-2021) & (USD Million)
Table 122. Middle East & Africa Anal Cancer Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Anal Cancer Picture
Figure 2. Global Anal Cancer Revenue Market Share by Type in 2020
Figure 3. Fluorouracil
Figure 4. Cisplatin
Figure 5. Carboplatin
Figure 6. Other
Figure 7. Anal Cancer Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Long-term care centers Picture
Figure 10. Pharmacies Picture
Figure 11. Other Picture
Figure 12. Global Anal Cancer Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Anal Cancer Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Anal Cancer Revenue Market Share by Region (2016-2026)
Figure 15. Global Anal Cancer Revenue Market Share by Region in 2020
Figure 16. North America Anal Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Anal Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Anal Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Anal Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Anal Cancer Market Drivers
Figure 21. Anal Cancer Market Restraints
Figure 22. Anal Cancer Market Trends
Figure 23. GlaxoSmithKline Recent Developments and Future Plans
Figure 24. Spectrum Pharmaceuticals Recent Developments and Future Plans
Figure 25. Hospira Recent Developments and Future Plans
Figure 26. Global BioPharma Recent Developments and Future Plans
Figure 27. Advaxis Recent Developments and Future Plans
Figure 28. Amgen Inc Recent Developments and Future Plans
Figure 29. Atara Biotherapeutics Recent Developments and Future Plans
Figure 30. Bayer Recent Developments and Future Plans
Figure 31. Cell Medica Recent Developments and Future Plans
Figure 32. Eli Lilly Recent Developments and Future Plans
Figure 33. Genticel Recent Developments and Future Plans
Figure 34. ISA Pharmaceuticals Recent Developments and Future Plans
Figure 35. Merck＆Co Recent Developments and Future Plans
Figure 36. Millennium Pharmaceuticals Recent Developments and Future Plans
Figure 37. Novartis Recent Developments and Future Plans
Figure 38. Ono Pharmaceutical Recent Developments and Future Plans
Figure 39. Oryx Recent Developments and Future Plans
Figure 40. PDS Biotechnology Recent Developments and Future Plans
Figure 41. Sun Pharma Recent Developments and Future Plans
Figure 43. Global Anal Cancer Revenue Share by Players in 2020
Figure 44. Anal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 45. Global Top 3 Players Anal Cancer Revenue Market Share in 2020
Figure 46. Global Top 10 Players Anal Cancer Revenue Market Share in 2020
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 48. Global Anal Cancer Revenue Share by Type in 2020
Figure 49. Global Anal Cancer Market Share Forecast by Type (2021-2026)
Figure 50. Global Anal Cancer Revenue Share by Application in 2020
Figure 51. Global Anal Cancer Market Share Forecast by Application (2021-2026)
Figure 52. North America Anal Cancer Sales Market Share by Type (2016-2026)
Figure 53. North America Anal Cancer Sales Market Share by Application (2016-2026)
Figure 54. North America Anal Cancer Revenue Market Share by Country (2016-2026)
Figure 55. United States Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Canada Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Mexico Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Europe Anal Cancer Sales Market Share by Type (2016-2026)
Figure 59. Europe Anal Cancer Sales Market Share by Application (2016-2026)
Figure 60. Europe Anal Cancer Revenue Market Share by Country (2016-2026)
Figure 61. Germany Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. France Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. United Kingdom Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Russia Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Italy Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Asia-Pacific Anal Cancer Sales Market Share by Type (2016-2026)
Figure 67. Asia-Pacific Anal Cancer Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Anal Cancer Revenue Market Share by Region (2016-2026)
Figure 69. China Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Japan Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South Korea Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. India Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Southeast Asia Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Australia Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South America Anal Cancer Sales Market Share by Type (2016-2026)
Figure 76. South America Anal Cancer Sales Market Share by Application (2016-2026)
Figure 77. South America Anal Cancer Revenue Market Share by Country (2016-2026)
Figure 78. Brazil Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Argentina Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Middle East and Africa Anal Cancer Sales Market Share by Type (2016-2026)
Figure 81. Middle East and Africa Anal Cancer Sales Market Share by Application (2016-2026)
Figure 82. Middle East and Africa Anal Cancer Revenue Market Share by Country (2016-2026)
Figure 83. Turkey Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Saudi Arabia Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. UAE Anal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
世界の肛門がん治療薬市場規模・現状・予測（2021年-2027年） A cancer can be defined when the normal cells lose their ability to control, their growth or multiplication and thus invade the tissues and spread to the body parts. Anal cancer is often called as squamous cell carcinoma which arises from the cells around or in the anal opening or in rare cases it m…- 世界の肛門がん市場規模・現状・予測（2021年-2027年） Anal cancer is a disease in which malignant (cancer) cells form in the tissues of the anus. Being infected with the human papillomavirus (HPV) increases the risk of developinganal cancer. Signs of anal cancer include bleeding from theanus or rectum or a lump near the anus. Market Analysis and Insigh…
- 世界の肛門・大腸がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anal and Colorectal Cancer Market The global Anal and Colorectal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界の肛門・大腸がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anal and Colorectal Cancer Market The global Anal and Colorectal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界の裂肛治療市場規模・現状・予測（2021年-2027年） An anal fissure is a painful medical condition where the anal canal has been torn and is accompanied by pain and bleeding during and after defecation. Market Analysis and Insights: Global Anal Fissure Treatment Market The global Anal Fissure Treatment market size is projected to reach US$ 2398.2 mil…